San Francisco Chronicle - The Voice of the West, 901 Mission Street, San Francisco, CA 94119 - Wednesday, April 16, 1997 - Page A1
Laura Castaneda, Chronicle Staff Writer
The announcement yesterday by Guarantee Trust Life Insurance Co. of Glenview, Ill., is significant because it recognizes the success of protease inhibitors in extending the lives of many AIDS patients.
"It's another step forward in acknowledging the power of new treatment options," said Timothy Rodrigues, a spokesman for the San Francisco AIDS Foundation.
"It's not for everybody, but it's a start in the right direction," said Betsy Johnsen, a benefits attorney for the AIDS Legal Referral Panel in San Francisco.
However, even Guarantee Trust said the cost of this new insurance may be too high for most people.
"We're excited about being able to offer this product, but there may not be a market for it," said Monty Edson, Guarantee Trust's senior vice president for marketing.
If the 90-day trial is successful, Guarantee Trust plans to roll out the plans nationally.
Many insurance specialists and AIDS activists believe the move by Guarantee Trust will encourage other insurers to begin offering life insurance products to people with HIV.
"We expect other insurance companies will be looking closely at this to see if they can design their own products," said Ken Vest, a spokesman for the Washington D.C.-based American Council of Life Insurance.
Guarantee Trust is offering whole life coverage ranging from $25,000 to $250,000 to people who are under 49 years of age and do not have full-blown AIDS. Other requirements for coverage include HIV treatment for at least nine months, T-cell counts no lower than 400, and an average viral load that has not exceeded 5,000 over the past year.
Edson said the company wants applicants to be working and insured so that they can afford to pay for their HIV treatments.
People who were infected with HIV from sharing needles during intravenous drug use are not eligible for the insurance, he said.
The price for the Guarantee Trust policies for people with HIV will be substantially higher than its impaired risk policies, said Edson.
With the standard impaired risk product, a 30-year-old man who doesn't smoke would pay between $55 and $110 a month for a $50,000 whole life policy. If that same person were HIV positive, the policy would cost about $300 a month.
With a whole life insurance policy, the face amount is constant and will be paid if the insured person dies at any time while the policy is in effect. Premium payments are fixed and remain the same from the effective date to maturity date.
Many insurance companies across the country offer so-called impaired risk life insurance for people who had organ transplants, cancer, heart problems or suffer from diabetes.
The only plans available to people with HIV are "guaranteed issue insurance" plans that do not ask about a person's health status, or group insurance plans. But guaranteed issue insurance is expensive, usually provides around $25,000 of coverage, and is typically limited to people age 50 or older. Edson said the Guarantee Trust plans have no restrictions on viatical settlements, where the terminally ill sell their policies for a fraction of their value.
Guarantee Trust, a 60-year-old company with more than 1 million customers and $175 million in assets, specializes in insuring impaired individuals.
970416
SC970402
Copyright © 1997 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com. http://www.sfgate.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .